A new $2 million grant from the Mt. Sinai Health Foundation has established the Mt. Sinai Fellows in Therapeutic Discovery, an effort to support the recruitment of exceptional mid-career MD/PhD researchers to participate in an interdisciplinary collaborative that includes CWRU's hospital partners.
Three recipients who received early-career support from the Mt. Sinai Health Foundation have been tapped to play key roles in the new initiative: Case CCC Developmental Therapeutic Program members Drew Adams, PhD, and Derek Taylor, PhD, and Cancer Genomics and Epigenomics Program member Paul Tesar, PhD.
According to Mitchell Balk, Mt. Sinai Foundation President, the initiative is necessary to ensure Cleveland has the talent to discover and develop effective treatments to improve patient outcomes.